They can evaluate your individual health profile and determine if this innovative treatment aligns with your goals
Weight regain and reversal of benefits According to a review published earlier this year in the British Medical Journal (BMJ) , the average rate of weight regain is 0.4 kg (.88 lbs)/month after stopping treatment at an average of 39 weeks, with weight and risk markers for diabetes and heart disease predicted to return to pre-treatment levels in less than two years
If you are considering stopping GLP-1 therapy, discuss a structured monitoring plan with your GP or specialist, including regular checks of HbA1c, weight, blood pressure and lipids
Before considering injections or surgery, many patients investigate non-surgical options
Contribue au mtabolisme nergtique normal
By defining candidacy through clinical criteria rather than generalized eligibility, MEDVi positions its semaglutide program as a targeted medical solution rather than a broad consumer product